U.S. Analgesics Market Size is USD 11.63 Billion by 2026

U.S. Analgesics Market (By Drug Type: Opioid, Non-opioid, Compound Medication; By Route of Administration: Oral, Parenteral, Transdermal, Others; By Application: Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain Due to Burns, Dental/Facial, Pediatric, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Industry Size, Share, Growth, Trends 2025 to 2035

Report Code : 1617 | Published : 08 Jun 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 11.02 Bn

Forecast Year,

USD 18.82 Bn

CAGR, 2026 - 2035

5.50%

Report Coverage

Worldwide

Download Databook

The U.S. analgesics market size was estimated at USD 11.02 billion in 2025 and is projected to be worth around USD 18.82 billion by 2035, is expanding at a CAGR of 5.50% from 2026 to 2035. Growing due to strong pharmaceutical innovation, high healthcare spending, and increasing adoption of prescription and OTC analgesics.

U.S. America Analgesics Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 11.02 Billion
Market Size in 2026	USD 11.63 Billion
Market Size by 2035	USD 18.82 Billion
CAGR 2026 to 2035	5.50%
Base Year	2025
Forecast Period	2026 to 2035

The shift from opioid-based treatments to nonaddictive substitutes under stringent regulations is a significant trend. Personalized pain management treatments and extended-release formulations are becoming more innovative. The market is also being shaped by the expansion of direct-to-consumer and online pharmacies.

High healthcare costs, the presence of major pharmaceutical companies, and the growing emphasis on novel non-opioid analgesic treatments are the market's main drivers. Growing use of e-pharmacy and telehealth platforms is also driving market expansion.

Segments	Shares (%)
Non-opioid	48%
Opioid	34%
Compound Medication	18%

Opioid- Opioid segment is notable with a market share of 34% driven by use in acute and cancer pain.
Non-opioid - Non opioid segment is dominating with a market share of 48% driven by a strong shift toward nonaddictive pain treatments. Regulatory pressure on opioid prescriptions is accelerating adoption.
Compound Medication - Compound medication segment is fastest growing, with a market share of 18% driven by personalized therapy demand. Advancements in compounding technologies are supporting expansion.

U.S. Analgesics Market, By Route of Administration, 2025

Segments	Shares (%)
Oral	52%
Parenteral	21%
Transdermal	15%
Others	12%

Oral - Oral route is dominating with a market share of 52% driven by high patient preference. Extensive availability of OTC medications is further boosting growth.
Parenteral - Parenteral route is notable with a market share of 21% driven by hospital and emergency care usage.
Transdermal - Transdermal route is fastest growing, with a share of 15% driven by innovation in drug delivery. Rising demand for long-acting pain relief is contributing to growth.

U.S. Analgesics Market, By Application, 2025

Segments	Shares (%)
Musculoskeletal	22%
Surgical and Trauma	14%
Cancer	10%
Neuropathic	9%
Migraine	8%
Dental/Facial	7%
Obstetrical	6%
Fibromyalgia	5%
Pediatric	6%
Others	9%
Pain Due to Burns	4%

Musculoskeletal - The musculoskeletal segment is dominating with a market share of 22% driven by the high prevalence of chronic pain conditions. Aging population is further supporting demand.
Surgical and Trauma - Surgical and trauma are fastest growing with a market share of 14% driven by increasing surgeries.
Cancer - The cancer segment is notable with a market share of 10% driven by oncology pain management needs. Growing cancer cases are sustaining segment demand.

U.S. Analgesics Market, By Distribution Channel, 2025

Segments	Shares (%)
Hospital Pharmacies	36%
Retail Pharmacies	46%
Online Pharmacies	18%

Hospital Pharmacies - Hospital pharmacies segment is notable with a market share of 36% driven by inpatient treatments. High hospital admission rates are supporting steady demand.
Retail Pharmacies - Retail pharmacies segment is dominating with a market share of 46% driven by strong OTC sales. Expansion of e-pharmacy platforms is further accelerating growth.

Top Companies in the U.S. Analgesics Market

Bayer AG
Endo International plc
Assertio Holdings, Inc.
Janssen Global Services, LLC
GSK plc
AbbVie Inc.
Novartis AG
Viatris Inc.
Teva Pharmaceutical Industries Ltd.

Segments Covered in the Report

By Drug Type

Opioid
Non-opioid
Compound Medication

By Route of Administration

Oral
Parenteral
Transdermal
Others

By Application

Musculoskeletal
Surgical and Trauma
Cancer
Neuropathic
Migraine
Obstetrical
Fibromyalgia
Pain Due to Burns
Dental/Facial
Pediatric
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

List of Tables & Figures

List of Tables

Table 1: U.S. Analgesics Market Size, by Drug Type, 2025-2035 (USD Billion)
Table 2: U.S. Opioid Market Size, 2025-2035 (USD Billion)
Table 3: U.S. Non-opioid Market Size, 2025-2035 (USD Billion)
Table 4: U.S. Compound Medication Market Size, 2025-2035 (USD Billion)
Table 5: U.S. Analgesics Market Size, by Route of Administration, 2025-2035 (USD Billion)
Table 6: U.S. Oral Market Size, 2025-2035 (USD Billion)
Table 7: U.S. Parenteral Market Size, 2025-2035 (USD Billion)
Table 8: U.S. Transdermal Market Size, 2025-2035 (USD Billion)
Table 9: U.S. Others Market Size, 2025-2035 (USD Billion)
Table 10: U.S. Analgesics Market Size, by Application, 2025-2035 (USD Billion)
Table 11: U.S. Musculoskeletal Market Size, 2025-2035 (USD Billion)
Table 12: U.S. Surgical and Trauma Market Size, 2025-2035 (USD Billion)
Table 13: U.S. Cancer Market Size, 2025-2035 (USD Billion)
Table 14: U.S. Neuropathic Market Size, 2025-2035 (USD Billion)
Table 15: U.S. Migraine Market Size, 2025-2035 (USD Billion)
Table 16: U.S. Obstetrical Market Size, 2025-2035 (USD Billion)
Table 17: U.S. Fibromyalgia Market Size, 2025-2035 (USD Billion)
Table 18: U.S. Pain Due to Burns Market Size, 2025-2035 (USD Billion)
Table 19: U.S. Dental/Facial Market Size, 2025-2035 (USD Billion)
Table 20: U.S. Pediatric Market Size, 2025-2035 (USD Billion)
Table 21: U.S. Others Market Size, 2025-2035 (USD Billion)
Table 22: U.S. Analgesics Market Size, by Distribution Channel, 2025-2035 (USD Billion)
Table 23: U.S. Hospital Pharmacies Market Size, 2025-2035 (USD Billion)
Table 24: U.S. Retail Pharmacies Market Size, 2025-2035 (USD Billion)
Table 25: U.S. Online Pharmacies Market Size, 2025-2035 (USD Billion)
Table 26: U.S. Market Share, by Drug Type, 2025 (%)
Table 27: U.S. Market Share, by Route of Administration, 2025 (%)
Table 28: U.S. Market Share, by Application, 2025 (%)
Table 29: U.S. Market Share, by Distribution Channel, 2025 (%)

List of Figures

Figure 1: U.S. Analgesics Market Share, by Drug Type, 2025 (%)
Figure 2: U.S. Analgesics Market Share, by Route of Administration, 2025 (%)
Figure 3: U.S. Analgesics Market Share, by Application, 2025 (%)
Figure 4: U.S. Analgesics Market Share, by Distribution Channel, 2025 (%)
Figure 5: U.S. Analgesics Market Forecast, 2025-2035 (USD Billion)
Figure 6: U.S. Opioid Market Forecast, 2025-2035 (USD Billion)
Figure 7: U.S. Non-opioid Market Forecast, 2025-2035 (USD Billion)
Figure 8: U.S. Compound Medication Market Forecast, 2025-2035 (USD Billion)
Figure 9: U.S. Oral Market Forecast, 2025-2035 (USD Billion)
Figure 10: U.S. Parenteral Market Forecast, 2025-2035 (USD Billion)
Figure 11: U.S. Transdermal Market Forecast, 2025-2035 (USD Billion)
Figure 12: U.S. Others Market Forecast, 2025-2035 (USD Billion)
Figure 13: U.S. Musculoskeletal Market Forecast, 2025-2035 (USD Billion)
Figure 14: U.S. Surgical and Trauma Market Forecast, 2025-2035 (USD Billion)
Figure 15: U.S. Cancer Market Forecast, 2025-2035 (USD Billion)
Figure 16: U.S. Neuropathic Market Forecast, 2025-2035 (USD Billion)
Figure 17: U.S. Migraine Market Forecast, 2025-2035 (USD Billion)
Figure 18: U.S. Obstetrical Market Forecast, 2025-2035 (USD Billion)
Figure 19: U.S. Fibromyalgia Market Forecast, 2025-2035 (USD Billion)
Figure 20: U.S. Pain Due to Burns Market Forecast, 2025-2035 (USD Billion)
Figure 21: U.S. Dental/Facial Market Forecast, 2025-2035 (USD Billion)
Figure 22: U.S. Pediatric Market Forecast, 2025-2035 (USD Billion)
Figure 23: U.S. Others Market Forecast, 2025-2035 (USD Billion)
Figure 24: U.S. Hospital Pharmacies Market Forecast, 2025-2035 (USD Billion)
Figure 25: U.S. Retail Pharmacies Market Forecast, 2025-2035 (USD Billion)
Figure 26: U.S. Online Pharmacies Market Forecast, 2025-2035 (USD Billion)

Research Methodology

Related Databooks

March 2026